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Sesterterpenoids account for many bioactive natural products, often with unusual and complex
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Ever since Komppa’s pioneering work on camphor,1 terpenoids
(i.e. regular terpenes and their partially degraded congeners)
have played a prominent role in the development of organic
synthesis. Many key concepts in organic chemistry, such as
Wagner Meerwein rearrangements, Diels Alder reactions, or
polyolefin cyclizations, were first explored with members of this
large natural product class. As the power of organic synthesisFakultat fur Chemie und Pharmazie, Ludwig Maximilians Universitat
Munchen, and Munich Center for Integrated Protein Science,
Butenandtstr. 5 13, 81377 Munchen, Germany. E mail: Dirk.Trauner@
lmu.de
752 | Nat. Prod. Rep., 2012, 29, 752 779grew, increasingly complex terpenoids have been targeted and
their successful total syntheses must now number in the
hundreds.
Within the terpenoid family, sesterterpenoids probably form
the smallest class, comprising less than a thousand known
compounds. They consist of two and a half (sester in Latin)
terpene units, which for historic reasons were defined as pieces
made of ten carbons. As such, sesterterpenoids contain 25 (or
slightly fewer) carbon atoms. They have been recovered from
a variety of sources, including lichens, higher plants, fungi,
insects and sponges, often showing significant biological activity
e.g. as anti inflammatory or cytotoxic agents.
With their comparatively large size, structural complexity, and
molecular diversity, sesterterpenoids represent highly attractive
targets for total synthesis and they have spurred many elegant
synthetic approaches. These are the subject of the present review,
which focuses specifically on the synthesis of sesterterpenoids
rather than their isolation, structure and biological evaluation.
We refer to the review series sesterterpenoids2 in this journal and
to similar accounts3 5 for details on these aspects. Furthermore,
we will limit our discussion to members of the class that have
attracted substantial attention from the synthetic community
and will largely ignore compounds where little or no synthetic
work has been reported.2 Linear sesterterpenoids
The natural products of this subclass possess a linear carbon
chain, which in most cases has been partially oxidized. Such an
oxygenation often leads to cyclization, resulting in furans and/or
lactones. In contrast to the other sesterterpenoid subclasses, no
additional C C bond is formed during biosynthesis. Although
numerous linear sesterterpenoids have been reported, very few
have been targeted by synthetic chemists to date.
In 1998, Romo and co workers reported the total synthesis of
(+) okinonellin B (1) (Scheme 1).6,7Retrosynthetic bifurcation ofThis journal is ª The Royal Society of Chemistry 2012
Scheme 1 Romo’s disconnection of (+) okinonellin B. Bn benzyl.
 
View Article Onlinethe natural product viaNegishi coupling allowed for its assembly
in a convergent manner. A b lactone 3 was employed to address
the stereoselective synthesis of the highly substituted g butyro
lactone within okinonellin B (1). The absolute configuration of
the isolated allylic stereocenter bearing a methyl group origi
nated from the commercially available (S) Roche ester (2). In
2001, Norizuki and co workers8 synthesized ( ) idiadione (4)9
starting from (S) citronellal, establishing the single stereogenic
center to be (S) configured (Fig. 1). Another linear fur
anosesterterpenoid, (18S) variabilin (5)10 was prepared effi
ciently by Yoda et al. in 2004,11 utilizing a lipase catalyzed
asymmetric desymmetrization to install the sole stereocenter.
Recently, Gomez and Fall accomplished the enantioselective
synthesis of (+) palinurin (6), which was found to act as a non
competitive inhibitor of GSK 3b, a kinase implicated in Alz
heimer’s desease.12,13 They achieved the synthesis via the chiral
auxiliary controlled diastereoselective alkylation of a tetronic
acid derivative and a series of standard olefinations to install theRobert Webster was born in Saskatoon, Saskatchewan, Canada
(1981). In 2004, he graduated from the University of Saskatch
ewan with a B.Sc. in chemistry (great distinction). Opting to
continue his studies at the University of Toronto, where his work
focused on terpenoid total synthesis and asymmetric rhodium
catalyzed reactions, he earned his Ph.D. in 2010 under the super
vision of Professor Mark Lautens. He is currently an Alexander
von Humboldt postdoctoral fellow exploring biomimetic natural
product total synthesis in the laboratories of Professor Dirk
Trauner at the LMU M€unchen.
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This journal is ª The Royal Society of Chemistry 2012double bonds with the required configurations. Similar to the
synthesis of okonellin B (1), the isolated allylic stereogenic center
bearing a methyl group was incorporated starting from the
(R) Roche ester ent (2).
Moenocinol (7)14 is an achiral sesterterpenoid alcohol isolated
as a hydrolysis product of the antibiotic moenomycin A, which is
produced by various Streptomyces strains (Fig. 1).15 Numerous
attempts to synthesize moenomycin A and its components have
been reported,16,17 including several syntheses of moenocinol (7)
itself by the groups of Tschesche,18 Grieco,19 Kocienski,20
Coates,21 Welzel,22 Schmidt,23 Yang24 and Hilt.25 This work has
already been thoroughly reviewed elsewhere,17 and consequently
will not be elaborated upon here.3 Monocarbocyclic sesterterpenoids
3.1 Manoalide
The sesterterpenoid (+) manoalide (8) was first isolated, along
with a number of structurally similar metabolites, in the early
1980s by de Silva and Schr€oder from the Pacific sponge Luffar
iella variablis (Fig. 2).26Although its structure is relatively simple,
bearing only one defined stereogenic center, manoalide (8) has
attracted substantial attention from synthetic chemists. This is
likely due to the fact that manoalide (8) is a potent and irre
versible inhibitor of phospholipase A2: the enzyme that catalyzes
arachidonic acid release from membrane bound phosphogly
cerides, resulting in the formation of pro inflammtory factors.27
In 1985, Katsumara et al. reported the first racemic synthesis of
manoalide (8),28 which was followed by six further syntheses of
the racemate by the groups of Garst,29 Katsamura,30 Kocienski31Dirk Trauner was born in Linz, Austria. After studying biology and
then biochemistry at theUniversity of Vienna, he joined the group of
Professor JohannMulzer at the Free University of Berlin to pursue
natural product synthesis. In the late 1990s, he was a postdoctoral
fellow with Professor Samuel J. Danishefsky at the Memorial
Sloan Kettering Cancer Center in New York City. In 2000, he
joined the University of California, Berkeley, where he rose through
the ranks to become an Associate Professor of Chemistry. In 2008,
he moved to the University ofMunich, where he currently resides as
a Professor for Chemical Biology and Genetics.
Daniel T. Hog was born (1984) and raised in Freiburg im Breis
gau, Germany, before moving to M€unster to study chemistry
(2004). After a research internship with Professor Antonio M.
Echavarren at ICIQ, Tarragona, Spain, he conducted his Diploma
research under the supervision of Professor Martin Oestreich at
WWU M€unster. In 2009, he joined the laboratories of Professor
Dirk Trauner at LMU M€unchen as a graduate student. He is
currently pursuing natural product synthesis of sesterterpenoids,
supported by a scholarship from the Fonds der Chemischen
Industrie.
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Fig. 2 The molecular structure of the sesterterpenoid (+) manoalide.
 
View Article Onlineand Hoffmann.32 However, only two enantioselective routes
toward manoalide (8) have been reported to date.
Almost twenty years after its isolation, Sodano and co
workers succeeded in the first asymmetric synthesis of
(+) manoalide (8) (Scheme 2).33 To this end, they prepared alkyl
iodide 10 starting from b ionone (9) and improved the yields of
the sequence leading to this compound previously reported by
Hoffmann.32 Sodano et al. envisaged utilizing an enantioselective
aldol reaction to install the single stereogenic center. Thus,
subjecting 3 furaldehyde (15) and silyloxydiene 11 to a mixture
of Ti(Oi Pr)4 and (R) BINOL (known as Sato’s procedure) gave
the corresponding aldol product (88% ee), which was subse
quently converted into ester 12 by microwave irradiation in
MeOH. This intermediate was then alkylated with homoallyl
iodide 10, requiring the presence of tetrabutylammonium salt 16
as a phase transfer catalyst to furnish, after diastereoselective
ketone reduction, furan 13. An ensuing three step protocol
generated lactone 14 via ester hydrolysis, acetylation with
concomitant lactonization and finally elimination of acetate in
the presence of DBU. Having obtained the corresponding lactol
by reduction with DIBAL H, Sodano et al. finally accessed
(+) manoalide (8) by photooxygenation of the furan moiety.
Several years later, in 2003, Kocienski et al. reported the
second enantioselective synthesis of (+) manaolide (8) (Scheme
3).34 In contrast to Sodano’s work, the single stereogenic center
was installed using a Sharpless kinetic resolution. However,
Kocienski opted to utilize the same homoallyl iodide 10 featured
in Sodano’s synthesis, that was also prepared from b ionone (9),
but using a different eight step protocol. Their second building
block was derived from furyl aldehyde 17, which was reacted
with propargyl magnesium bromide to afford racemic prop
argylic alcohol 18. Exposure of the alcohol to Sharpless
asymmetric epoxidation conditions afforded the desired
(R) configured alcohol 18 in 41% yield. Successive Mo catalyzed
cycloisomerisation in the presence of Bu3SnOTf led to vinyl
stannane 19, the required intermediate for their second key step:
a Cu mediated 1,2 metalate rearrangement. For this purpose,Fig. 1 Molecular structures of successfully synthesized linear
sesterterpenoids.
754 | Nat. Prod. Rep., 2012, 29, 752 779exposure of stannane 19 to s BuLi generated the corresponding
vinyl lithium species, which was then added to mixed cuprate 21
previously prepared from homoallyl iodide 10, t BuLi and
1 pentynylcopper. This procedure triggered the rearrangement to
form an intermediate vinyl cuprate species that was quenched
with I2 to generate vinyl iodide 20. With this compound in hand,
only three steps remained to finish the synthesis: a Pd catalyzed
carbonylation yielded a lactone that was subsequently reduced
by DIBAL H to the corresponding lactol. Similar to Sodano’s
endgame, photooxidation of the furan moiety in the presence of
Rose Bengal gave rise to (+) manoalide (8).
Within the synthesis of (+) manoalide (8) Kocienski and co
workers took advantage of a 1,2 metalate rearrangement,
a methodology, which had been applied earlier in the sameScheme 2 Sodano’s asymmetric synthesis of (+) manoalide. TMS tri
methylsilyl, BINOL 1,10 bi(2 naphtol), Ac2O acetic anhydride, py
pyridine, DBU 1,8 diazabicyclo[5.4.0]undec 7 ene, DIBAL H diiso
butylaluminum hydride.
This journal is ª The Royal Society of Chemistry 2012
 View Article Onlinelaboratories en route to the related natural product luffariolide E
(26) (Scheme 4).35,36 The 1,2 metalate rearrangement, the same
key step used in Kocienski’s synthesis of manoalide (8), was
carried out using vinyl stannane 22 and cuprate 27. Treating
stannane 22 with n BuLi generated the corresponding organo
lithium species, which was then reacted with dialkyl cuprate 27 to
form higher order cuprate 23. The latter rearranged with inver
sion of the alkene geometry to yield alkenyl cuprate 24. In
contrast to their synthesis of manoalide (8), the sequence was not
terminated by quenching with I2, but by direct carboxylation and
subsequent esterification to give the (Z) configured alkene 25 in
an overall yield of 48%. Three further transformations gave rise
to (3R,4R) luffariolide E (26) in racemic form, but the NMR
data did not match that of the isolated natural product. There
fore, the authors concluded by chemical correlation to related
natural products of known absolute configuration35 that natural
luffariolide E (26) possesses the (3S,4R) configuration. More
over, Kocienski et al. prepared racemic (3S,4R) luffariolide E
later that year, verifying their conclusion.373.2 Diumycinol
Another compound targeted within this subclass of sesterterpe
noids is diumycinol (28) (Fig. 3).38 In analogy to its acyclic isomer
moenocinol (7) (Section 2), this sesterterpenoid alcohol is
a hydrolysis product from moenomycin type antibiotics, more
precisely from diumycin. While there was initially some contro
versy concerning whether these alcohols truly arise from
a terpenoid origin, it has been shown that they are indeed formed
via the non mevalonate pathway from a C10 and a C15Scheme 3 Kocienski’s asymmetric synthesis of (+) manoalide. TES
triethylsilyl, DIPT diisopropyl tartrate, DIBAL H diisobutyl
aluminium hydride, Bu3SnOTf tributylstannyl trifluoromethane
sulfonate.
This journal is ª The Royal Society of Chemistry 2012precursor.39 In contrast to moenocinol (7), however, diumycinol
(28) has attracted less attention from synthetic groups and only
two racemic syntheses by the groups of Grieco40 and Kocienski41
have been reported. These findings have recently been reviewed
in detail by Wenzel in an overview of syntheses dealing with the
transglycosylation step in peptidoglycan biosynthesis.173.3 Ceriferic acid derivatives
A series of macrocyclic sesterterpenoids, including ceriferic acid
(29), its methyl ester 30 and ceriferic acid I (32), imbued with
a cembrenoid 14 membered ring, were isolated in the late 1970s
from the wax secreted by the Japanese scale insect Cerplastes
ceriferus (Fig. 4).42 Two groups, namely Kato’s and Kodama’s,
were responsible for the synthesis of ceriferol (31),43 ceriferol I
(34),44 methyl ceriferate I (33),44 and the deoxygenated analogue
cericerene (35).45 None of the above syntheses were asymmetric,
so the lone stereocenter (tentatively assigned as (R) by Naya42d
based on analogy to the optical rotation of related hydrocar
bons) has not been unambiguously assigned.
Kato’s synthetic work43,45 in the early 1980s was instrumental
for elucidating the structures of this sesterterpenoid subclass.
Both ceriferol (31) and ceriferol I (34), isomers differing by the
position of a double bond, were synthesized starting from ger
anylgeranyl acetone (36) (Scheme 5). The key step, a surprisingly
efficient and selective Friedel Crafts type macrocyclization of
acid chloride 37, was mediated by SnCl4 to close the
14 membered ring and produce b chloro ketone 38 in 97% yield.
Elimination of chloride from the side chain of ketone 38 was
unselective, giving a 1 : 1 mixture alkenes that were thenScheme 4 Mechanistic details of the 1,2 metalate rearrangement: the
key step from Kocienski’s syntheses of luffariolide E and (+) manoalide.
rt room temperature, HMPA hexamethylphosphoramide.
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 View Article Onlineseparated, and each was carried through a sequence of synthetic
manipulations to afford racemic ceriferol (31) and ceriferol I
(34), respectively.
In 1986, Kodama reported a racemic synthesis of methyl cer
iferate I (33) (Scheme 6).44 The coupling of allyl bromide 39 and
geraniol derived sulfide 43 under basic conditions furnished
dioxolane 40 that was later desulfurized and deprotected to give
aldehyde 41. The side chain was appended using ester 44, and
after an eleven step protocol, including a Claisen rearrangement,
the cyclization precursor, phosphonate 42, was obtained.
Treatment of phosphonate 42 with NaH in DME succeeded
in Horner Wadsworth Emmons macro cyclization, but gave
methyl ceriferate I (33) as the minor double bond isomer along
with the undesired cis isomer as the major product (not shown).Fig. 4 Molecular structures of ceriferic acid and related
sesterterpenoids.4 Bicarbocylic sesterterpenoids
4.1 Terpestacin
The fungal metabolite terpestacin (45) was first isolated by Oki
and co workers in 1993 and its relative configuration was
unambiguously confirmed by X ray crystallography (Fig. 5).46
Terpestacin (45) was shown to inhibit the formation of syncytia,
i.e. multinuclear cell bodies, which are part of the pathology of
HIV infection. This property, in addition to its interesting
structural features, which include a 15 membered carbomacro
cycle with three trisubstituted olefins and four stereogenic
centers, was due cause for capturing the attention of several
synthetic groups.47 Successful approaches to this target prior to
2007 have been reviewed in some detail by Maimone and
Baran.48Nevertheless, this section will present an overview of the
topic that includes the additional material published since 2007.
In 1998 Tatsuta et al. reported a racemic synthesis,49 and later
that year the first enantioselective route to terpestacin (45).50
They followed an ex chiral pool strategy, using tri O acetyl D
galactal as a starting material (38 linear steps, not shown).
Tatsuta’s successful syntheses not only verified the structure of
terpestacin, but also confirmed its absolute configuration. Since
then, four additional syntheses have appeared in literature by the
groups of Myers,51 Jamison,52 Trost53 and Tius.54
The Myers group successfully completed the asymmetric total
synthesis of terpestacin (45) in 2002 in 19 steps and an overall
yield of 5.8%.51 Their route employed a sequence of diastereo
selective enolate alkylations, starting from optically pure amide
47 that was obtained via allylation of (R,R) pseudoephedrine
propionamide, exploiting a methodology previously developed
in the same laboratories (Scheme 7). Subsequent diaster
eoselective iodolactonization led to d lactone 48 with concomi
tant cleavage of the chiral auxiliary. The resulting alkyl iodide
was transformed into an alcohol, followed by TIPS protection to
give lactone 49, thus setting the stage for a secondFig. 3 The structure of the sesterterpenoid alcohol diumycinol.
756 | Nat. Prod. Rep., 2012, 29, 752 779diastereoselective enolate alkylation. The bulky TIPS ether was
postulated to direct si face attack from the allylic bromide 56 to
generate the desired quaternary stereocenter in lactone 50 with
good fidelity (dr 8.8 : 1). Installation of the allylic iodide and
cyclopentenone moiety in compound 51 required four steps and
generated the requisite functionality for a third enolate alkyl
ation to close the macrocycle. This reaction took place smoothly
using Masamune’s base in high dilution (0.002 M) and con
structed the desired trans fused [13.3.0] bicycle 52 with accept
able stereocontrol (trans:cis¼ 4.8 : 1). An aldol reaction with the
(Z) ketene acetal 57, derived from tert butyl propionate, intro
duced the desired three carbon chain selectively from the b face,
giving rise to alcohol 53. Subsequent two step reduction of the
ester functionality was accompanied by cleavage of the silyl enol
ether and produced a hemiketal that was chemoselectively
dehydrated using Martin’s sulfurane. Epoxidation of the result
ing cyclic enol ether 54 with DMDO and ring opening under
acidic conditions yielded the presumed triol 55 as an interme
diate, which collapsed via isomerisation and dehydration when
treated with methanolic K2CO3. Finally, cleavage of the TBS
group with 1 N HCl in THF gave rise to ( ) terpestacin (45).Scheme 5 Kato’s acylative macrocyclization approach to ceriferol.
This journal is ª The Royal Society of Chemistry 2012
Scheme 6 Kodama’s racemic synthesis of methyl cerifate I. DABCO
1,4 diazabicyclo[2.2.2]octane, DME 1,2 dimethoxyethane, pTsOH
p toluenesulfonic acid.
Fig. 5 Molecular structures of ( ) terpestacin and ( ) fusaproliferin.
Ac acetyl.
 
View Article OnlineInterestingly, despite the absolute configuration of Myers’
synthetic ( ) terpestacin (45) matching the configuration
assigned by Tatsuta in 1998, Myers’ optical rotation measure
ment was in disagreement with the previously reported values
from both Tatsuta (synthesis) and Oki (isolation), who reported
terpestacin (45) to be dextrorotary. Upon careful investigation,
Myers et al. concluded that the earlier reports contained arte
factually erroneous measurements caused by chloroetherification
of terpestacin (45) initiated by CHCl3, the solvent used for the
optical rotation measurement. They found that prolonged
exposure of ( ) terpestacin (45) to CHCl3 formed a chlorinated
product (not shown) that was dextrorotary with a larger
magnitude than ( ) terpestacin (45) itself. Myers et al. dispelled
the ambiguity of the stereochemical assignment and successfully
synthesized ( ) fusaproliferin (46)55 from ( ) terpestacin (45) in
two additional steps by bisacetylation and mono deacetylation,
verifying the assignment of its absolute configuration as well.
The following year, the third enantioselective synthesis of
( ) terpestacin (45) was disclosed by Jamison’s group,52 utilizing
a stereoselective intermolecular reductive coupling between an
alkyne and an aldehyde, a methodology that was conceived in
their laboratories. In contrast to Myers’ strategy, Jamison
installed the three carbon side chain at the beginning of theThis journal is ª The Royal Society of Chemistry 2012synthesis using an NMO promoted Pauson Khand reaction
between dicobalt complex 58 and enantiomerically pure dihy
drofuran 59, yielding bicycle 60 with complete control of regio
and diastereoselectivity (Scheme 8). The latter was transformed
into the desired alkyne 61 over a five step sequence via cuprate
addition, reduction (both occurring from the convex face),
desilylation, alkyne isomerisation and finally TMS protection of
the resulting alcohol. The aldehyde fragment 63 was prepared in
a straightforward manner from diol 62, that was in turn obtained
from (E,E) farnesyl acetate by chemo and enantioselective
dihydroxylation. When the key aldehyde/alkyne coupling step
was attempted using Ni(cod)2 with Et3B and Bu3P, the reaction
exhibited low regioselectivty (1.5 : 1) and no diastereoselectivity
(1 : 1). Fortunately, replacing Bu3P with a P chiral phosphine
ligand 64 enabled the formation of the desired alcohol 65 with
enhanced regioselectivity (2 : 1) and modest, but synthetically
useful diastereoselectivity (3 : 1). Following functional group
manipulation, the macrocycle was closed by intramolecular
alkylation, similar to Myers’ synthesis, using a cyclopentanone
enolate generated from LiHMDS to give tricycle 66. The next
challenge the team was confronted with was the installation of
the quaternary stereogenic center at C1. Notably, they discov
ered that the presence of H2O was crucial to achieve a successful
a alkylation with NaH/MeI in toluene, which was attributed to
producing finely dispersed NaOH in situ. Three further trans
formations, namely deprotection, a hydroxylation via a potas
sium enolate and ring opening of the resulting hemiketal
followed by enolization led to the completion of the synthesis of
( ) terpestacin (45).
Later, in 2007, Trost and co workers published the fourth
enantioselective total synthesis of ( ) terpestacin (45), exploiting
the unusual reactivity of the diosphenol moiety (a cyclic 1,2
diketone with one ketone existing as an enol).53 They planned to
introduce chirality using the Pd catalyzed asymmetric allylic
alkylation (AAA) methodology previously developed in their
laboratories. The crucial macrocyclic ring closure was envisaged
to proceed by means of a ring closing metathesis (RCM). Stereo
convergent O alkylation of commercially available diosphenol
67 with racemic isoprene monoepoxide (76), employing AAA
reaction conditions in the presence of Pd2dba3 and ligand (R,R)
74, provided (after subsequent TIPS protection) allyl vinyl ether
68 in high yield (95%) and enantioselectivity (88 96% ee)
(Scheme 9). A Claisen rearrangement was used to install the
quaternary center, followed by a Saegusa Ito oxidation to form
an a keto enone (not shown). The latter underwent a diastereo
selective 1,4 Sakurai allylation to furnish cyclopentenone 69,
which in turn was converted into allylic bromide 70 over a simple
three step sequence. This newly formed bromide 70 was then
coupled to the dianion of sulfone 75 via alkylation, followed by
a Pd catalyzed reductive desulfurization to cleanly afford RCM
precursor 71. Optimal results were observed with Grubbs’ second
generation catalyst, delivering the desired (E) configured mac
rocycle 72, albeit in moderate yield (35 44%). The final task
remaining was to install the three carbon side chain. This
problem was solved with a second AAA/Claisen rearrangement
sequence. After PMB deprotection, allylic carbonate 77 was
exposed to AAA conditions to facilitate O alkylation of the
macrocycle’s diosphenol moiety, immediately followed by
a Claisen rearrangement under microwave irradiation.Nat. Prod. Rep., 2012, 29, 752 779 | 757
Scheme 7 Myers’ enantioselective synthesis of ( ) terpestacin and ( ) fusaproliferin employing a series of three diastereoselective enolate alkylations.
TIPS triisopropylsilyl, KHMDS potassium hexamethyldisilazide, Red Al sodium bis(2 methoxyethoxy)aluminum hydride, Martin’s sulfurane
bis[a,a bis(trifluoromethyl)benzyloxy]diphenylsulfur, DMDO 3,30 dimethyldioxirane, Ac2O acetic anhydride, Ac acetyl.
Scheme 8 Jamison’s asymmetric synthesis of ( ) terpestacin utilizing a Ni catalyzed intermolecular aldehyde/alkyne coupling. NMO N methyl
morpholine N oxide, cod 1,5 cyclooctadiene, TMS trimethylsilyl, TBSOTf tert butyldimethylsilyl trifluoromethanesulfonate, TIPS triiso
propylsilyl, TBAF tetrabutylammonium fluoride, KHMDS potassium hexamethyldisilazide.
758 | Nat. Prod. Rep., 2012, 29, 752 779 This journal is ª The Royal Society of Chemistry 2012
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 View Article OnlineReprotection of the diosphenol gave PMB ether 73 as a virtually
single diastereomer (>15 : 1) emerging from the overall reaction
sequence. Only a short series of transformations remained
necessary to complete the synthesis, including a reagent
controlled Sharpless asymmetric dihydroxylation with AD mix
a to oxidize the disubstituted side chain alkene chemoselectively
in the presence of three trisubstituted alkenes. Following
deprotection, Trost’s group successfully synthesized ( ) terpes
tacin (45) in a total of 21 steps (longest linear sequence).
In the same year, Tius reported a 15 step synthesis of terpes
tacin (45) with an overall yield of 6.4%, albeit in a racemic
fashion.54 They envisaged the core a hydroxy enone structure
originating from an allene ether Nazarov cyclization as a key
step, forming one stereogenic center, which in turn would set all
other stereogenic centers in the target. To this end, g butyro
lactone (78) was subjected to an one pot aldol/dehydration
process with aldehyde 85, then a subsequent isomerization
protocol yielded the (E) configured lactone 79 in 66% yield
(Scheme 10).54b After the addition of allenic lithium species 86 to
lactone 79, generating a hemiacetal (not shown), treatment with
acid triggered the desired Nazarov cyclization and MOM
deprotection to yield cyclopentenone 80. This was followed by
a two step sequence involving acetonide formation and
diastereoselective hydrogenation to furnish enone 81. Having
installed the quaternary stereogenic center in cyclopentenone 82,
by alkylating the lithium enolate from ketone 81 with allylic
bromide 87, Tius’ group turned their attention to closing the
macrocyclic ring. In contrast to the previously discussed
syntheses (but in analogy to the synthesis of Tatsuta), they
planed to achieve this goal using a Horner Wadsworth EmmonsScheme 9 Trost’s asymmetric synthesis of ( ) terpestacin exploiting an AAA
dibenzylideneacetone, TIPSOTf triisopropylsilyl trifluoromethanesulfonat
ammonium fluoride, LiHMDS lithium hexamethyldisilazide, dppp 1,3 b
This journal is ª The Royal Society of Chemistry 2012reaction. Liberation of the free alcohol functionalities in phos
phonate 82 by treatment with Et3N$HF, followed by DMP
oxidation of both the primary and the secondary alcohols
afforded the keto aldehyde macrocyclization precursor, which
smoothly underwent macrocyclization in the presence of H€unig’s
base and LiCl, giving rise to tricycle 83. Subsequently, a chemo
and diasteroselective (dr 4 : 1) reduction of enone 83was attained
by exposure to a 1 : 1 mixture of tert BuLi/DIBAL H, and the
resulting alcohol was protected as its TES silyl ether. Tius
installed the last remaining methyl group in the side chain using
a vinylogous enolate alkylation, leading to TES ether 84. Despite
the stereochemical outcome being the opposite required for ter
pestacin (45), it proved possible to invert the methyl group by
formation of the corresponding TBS dienol ether and reproto
nation with Cl3CCOOH at low temperature. Finally, simulta
neously cleavage of the TES ether and acetonide protecting
groups with 1 N HCl gave rise to racemic terpestacin (45).4.2 Dysidiolide
The bicarbocyclic sesterterpenoid ( ) dysidiolide (88) was iso
lated in 1996 and its relative configuration was established
unambiguously by X ray crystallography (Fig. 6).56 The
hydroxybutenolide moiety undergoes rapid exchange at C25,
resulting in a diastereomeric mixture. However, upon crystalli
zation, this carbon exclusively assumes the configuration
diagrammed below. A further remarkable feature of its geometry
is that the large side chains each occupy axial and pseudoaxial
positions on the same face of its decalin system./Claisen rearrangement sequence and an RCM macrocyclization. dba
e, TMS trimethylsilyl, PMB p methoxybenzyl, TBAF tetrabutyl
is(diphenylphosphino)propane, Boc tert butyloxycarbonyl.
Nat. Prod. Rep., 2012, 29, 752 779 | 759
Fig. 6 The molecular structure of the bicarbocyclic sesterterpenoid
( ) dysidiolide.
 
View Article OnlineIn addition to its novel carbon skeleton at the time of its
discovery, dysidiolide (88) was the first natural product reported
to inhibit protein phosphatase cdc25a, an enzyme involved in
dephosphorylation of cyclin dependent kinases, which have been
proposed as potential anti cancer targets. Early results showed
that dysidiolide (88) inhibits growth of A 549 human lung
carcinoma and P388 leukemia cell lines.57 Not surprisingly,
a large number of synthetic chemists were drawn to dysidiolide
(88) as a target, which culminated in several total and formal
total syntheses. As a detailed discussion of all these approaches
would exceed the range of this review, we will focus in the
following on three successful syntheses by Corey,58 Dani
shefsky59 and Forsyth.60
Just one year after its isolation, Corey’s group presented the
first route to ( ) dysidiolide (88).58 They commenced their
synthesis from the Wieland Miescher ketone analogue 89, that
was readily available in enantiomerically pure form (Scheme 11).
A second quaternary stereogenic center was incorporated by
Birch reduction and trapping of the resulting lithium enolate
with allyl bromide, after which an enone was introduced by
means of a sulfoxide elimination. This was followed by aMichael
addition of TMS Li to generate b silyl ketone 90, the purpose of
which will be explained below. In a series of ten transformations,
Corey converted ketone 90 into alcohol 91 by means of standard
reactions as e.g. dihydroxylation, NaIO4 cleavage, Wittig
methylenation and a diastereoselective hydrogenation using
Wilkinson’s catalyst. Having obtained alcohol 91, the stage was
set for a biosynthetically inspired key step to construct the fully
substituted bicyclic core of dysidiolide (88). Thus, treatment ofScheme 10 Tius’s racemic synthesis of terpestacin via an allene Nazarov cy
azide, TsCl p toluenesulfonyl chloride, DBU 1,8 diazabicyclo[5.4.0]und
propylamide, DMP Dess Martin periodinane, DIPEA diisopropylethy
HMPA hexamethylphosphoramide, TBSOTf tert butyldimethylsilyl trifl
760 | Nat. Prod. Rep., 2012, 29, 752 779tertiary alcohol 91 with gaseous BF3 initiated the formation of
a tertiary carbocation, triggering a methyl shift to form the
desired quaternary stereogenic center, facilitated by the neigh
boring TMS group due to hyperconjugation. The reaction was
terminated by an elimination, extruding the TMS group and
generating alkene 92 with the desired double bond regiochem
istry. To extend the northern side chain, it was first necessary to
cleave the primary TBS ether with PPTS and substitute the
resulting alcohol for an iodide (not shown) prior to displacement
with iso propenyl cuprate 95. An additional two steps, namely
deprotection of the primary alcohol and DMP oxidation yielded
aldehyde 93. One drawback late in the synthesis, however, was
that addition of furan 3 yl lithium (96) to aldehyde 93 formed
alcohol 94 as a mixture of diastereomers (1 : 1). To solve this
problem, the (S) configured alcohol 94 was oxidized to theclization. TIPS triisopropylsilyl, LiHMDS lithium hexamethyldisil
ec 7 ene, PPTS pyidinium p toluenesulfonate, LDA lithium diiso
lamine, DIBAL H diisobutylaluminum hydride, TES triethylsilyl,
uoromethanesulfonate, MOM methoxymethyl.
This journal is ª The Royal Society of Chemistry 2012
 View Article Onlinecorresponding ketone, followed by a diastereoselective CBS
reduction to give almost exclusively the (R) configured alcohol
94. Ultimately, the photooxygenation of a furan utilizing Rose
Bengal (Section 3.1 on manoalide) gave rise to ( ) dysidiolide
(88) and thus established its absolute configuration.
The straightforward, but nevertheless linear synthesis by
Corey started with the bicarbocyclic core of dysidiolide (88)
already in place. In contrast, the convergent approach of Dani
shefsky and co workers involved generating a more highly
functionalized bicycle via an intermolecular Diels Alder reac
tion.59 Their syntheses were reported almost contemporaneously,
although Danishefsky’s route was not enantioselective. At the
beginning of the synthesis, Danishefsky et al. subjected dioxolane
97 to dimethyl cuprate followed by trapping of the resulting
anion with ethyl iodoacetate (102) (Scheme 12). A subsequent
reduction and silylation sequence furnished compound 98, which
served as a masked dioxolenium dienophile. The other cycload
dition partner, diene 100, was assembled from lithium enolate 99
and alkyl iodide 103, by successive enol triflate formation and
Stille coupling to vinyl stannane 104. The key Gassman Diels
Alder reaction was carried out using TMSOTf as an acid catalyst
(to activate dioxolane 98, proceeding through the dioxolenium
cation intermediate), in good yield with the desired regio and
diastereoselectivity. As the bicycle 101 possessed the six stereo
genic centers of dysidiolide (88) with the correct relative stereo
chemistry, as well as the complete northern side chain, all that
remained necessary were minor functional group interconver
sions and elaboration of the southern appendage. This was
accomplished first by a Wolff Kishner reduction that was
accompanied by desilylation, and TPAP/NMO oxidation to
yield aldehyde 93, the same intermediate as in Corey’s synthesis.
Danishefsky completed the synthesis in a similar fashion to
Corey, by nucleophilic attack of 3 furyllithium (96) and a pho
tooxgenation in the presence of Rose Bengal (Scheme 11). TheScheme 11 Corey’s asymmetric synthesis of ( ) dysidiolide. LDA lithium
thylsilyl, HMPA hexamethylphosphoramide, TBS tert butyldimethylsily
nate, TBAF tetrabutylammonium fluoride, DMP Dess Martin periodin
This journal is ª The Royal Society of Chemistry 2012same diasteroselectivity problem from nucleophilic attack of the
furyllithium species 96 onto aldehyde 93 was faced, but Dani
shefsky’s solution was to separate the isomeric products and
invert the stereochemistry of the undesired alcohol 94 using
Mitsunobu conditions.
Most of the other published syntheses of dysidiolide (88) are
based on intermolecular Diels Alder reactions. A number of
groups have employed the useful building block 106 that is
readily available in enantiomerically pure form starting from
racemic 2 methylcyclohexanone (105) using a method from
d’Angelo (Scheme 13).61Among these groups are Boukouvalas,62
Shirai63 and Jung64 who accomplished enantioselective total or
formal total syntheses of ( ) dysidiolide (88) using similar Diels
Alder approaches. Furthermore, Waldmann et al. prepared
a model system containing the decalin core,65 which was
accompanied by the solid phase synthesis of analogues to carry
out SAR studies.66 Additionally, the group of Yamada reported
both a racemic67 and an asymmetric68 total synthesis of
( ) dysidiolide (88), also utilizing an intramolecular Diels Alder
reaction. Recently, Kaliappan and Gowrisankar reported
a racemic formal total synthesis of dysidiolide (88) based on
a dienyne metathesis to construct the dienophile portion.69
In 2000, however, Forsyth presented a conceptually different
approach to racemic dysidiolide (88) featuring a diastereo
selective sequential chirality transfer to install the stereogenic
centers on its core.60 His synthesis commenced with a diastereo
selective anti alkylation of racemic keto ester 107, which was
followed by vinylogous ester formation and reductive 1,3
carbonyl transposition to yield enone 108 (Scheme 14). After
protecting the primary alcohol as its TMS ether, the resulting
enone was reacted with the higher order cyanocuprate generated
from bromide 112, t BuLi and CuCN to afford, after silyl ether
cleavage, diol 109. Having conducted a double oxidation with
Jones’ reagent and subsequent esterification of the resulting freediisopropylamide, mCPBA m chloroperbenzoic acid, TMS trime
l, TBDPS tert butyldiphenylsilyl, PPTS pyridinium p toluenesulfo
ane.
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Scheme 12 Danishefsky’s racemic synthesis of dysidiolide, TBDPS tert butyldiphenylsilyl, Tf2O trifluoromethanesulfonic anhydride, TMSOTf
trimethylsilyl trifluoromethanesulfonate, Mont. K10 montmorillonite K10, TPAP tetrapropylammonium perruthenate, NMO N methyl
morpholine N oxide.
 
View Article Onlineacid, Forsyth closed the six membered ring by means of an
intramolecular aldol condensation in the presence of KOt Bu,
yielding decalin 110. The latter was treated with a cuprate
prepared from bromide 113, t BuLi, CuI, PBu3 and BF3 etherate
to produce exclusively the 1,4 adduct 111 as a single diaste
reomer with respect to the newly formed quaternary stereogenic
center (the stereochemistry at the ring junction was not assigned).
The authors commented that other cuprate reagents, such as
those first described by Yamamoto, and other additives such as
TMSCl offered no improved reactivity. Finally, a six step
protocol led to aldehyde 93, the common intermediate from the
Corey and Danishefsky syntheses, that was converted to racemic
dysidiolide (88) as previously described (Scheme 11). Other
racemic formal syntheses by the groups of Piers70 and Maier71
were published in the same year, also opting to close the decalin
system utilizing an intramolecular aldol condensation.
4.3 Miscellaneous bicarbocyclic sesterterpenoids
Apart from the two natural products discussed in the sections
above, various other bicarbocyclic sesterterpenoids have been
successfully synthesized during the past 20 years. The natural
products (+) cladocoran A (114)72 and (+) cladocoran B (115)72
closely resemble dysidiolide (88), differing only by location of the
alkene present in the decalin system. Their structures were
originally misassigned after isolation, but total syntheses by the
groups ofMarcos73 and Yamada74 allowed for structural revision
as depicted in Fig. 7. The synthesis of another structurally related
natural product, (+) dysideapalaunic acid (116),75 was disclosed
in 1991 by Hagawira and Uda.76 The authors chose to build
around the decalin core, starting from a readily available enan
tiomerically pure Wieland Mischer ketone analogue. In 1987,
Piers and Wai77 had reported a racemic synthesis of theScheme 13 d’Angelo’s asymmetric synthesis of d ketoester 106.
762 | Nat. Prod. Rep., 2012, 29, 752 779antimicrobial sesterterpenoid (+) palauolide (117)78 in 17 steps.
Starting from 3,6 dimethylcyclohex 2 enone, they successfully
installed the four contiguous stereogenic centers in the first four
steps of their synthesis, while the remaining 13 steps adjusted the
oxidation states and elaborated the side chain (not shown).
Two decades later, in 2002, Cheung and Snapper79 published
the total synthesis of the potent anti inflammotory marine
metabolite (+) cacospongionolide B (118).80 Within the short
twelve step sequence, Snapper utilized an RCM to close theScheme 14 Forsyth’s racemic synthesis of dysidiolide. TMS trime
thylsilyl, pTsOH p toluenesulfonic acid, TBS tert butyl
dimethylsilyl.
This journal is ª The Royal Society of Chemistry 2012
Fig. 7 Molecular structures of successfully synthesized bicarbocyclic
sesterterpenoids. Ac acetyl.
 
View Article Onlinedihydrofuran moiety. Recently, the laboratories of Basabe81
published an enantioselective route to the marine metabolite
(+) luffalactone (119)82 relying on a Yamaguchi lactonization
and a photochemical oxidation of a furan as key steps.
Two other marine natural products, ( ) ircinianin (120)83 and
its cyclic isomer (+) wistarin (121)84 have been the target of
several synthetic studies (Scheme 15).85 While Yoshii and
Takeda86 achieved an elegant biomimetic racemic synthesis of
ircianinin (120), inspired by a biogenetic hypothesis put forward
by Hofheinz,83 Uenishi and co workes re examined this route
eleven years later, completing an enantioselective synthesis in
1997.87 They synthesized aldehyde 122 starting from the (R)
Roche ester ent (2) (Section 2), which in turn underwent
a Nozaki Hiyama Kishi (NHK) reaction with vinyl iodide 123,
followed by an intramolecular Diels Alder reaction to furnish
the tricyclic adduct 124 in 60% yield. It is worth noting, the
epimeric alcohol also formed in the NHK coupling did not
cyclize spontaneously at room temperature, and could be iso
lated from the reaction mixture (not shown). Further deoxy
genation and demethylation led to ( ) ircinianin (120), which
was converted to (+) wistarin (121) by iodoetherification and
subsequent reductive deiodination. Interestingly, wistarin (121)
was the first example of a sesterterpenoid that occurs naturally in
both enantiomeric forms.88
Another family of bicarbocyclic sesterterpenoids, the leuco
sceptroids,89 represented by (+) leucosceptroid A (125)89a and
(+) leucosceptroid D (126)89b has recently attracted the attention
of Horne and co workers (Scheme 16).90 Isolated in 2010 and
2011 from the small tree Leucosceptrum canum, these natural
products possess anti feedant and anti fungal properties,
provoking the authors to give them the moniker ‘harbor defen
sive sesterterpenoids.’ Horne planned to use an intramolecular
Diels Alder reaction to close the central six membered ring, and
in their 2011 report, they described the synthesis of the Diels
Alder precursor, triene 127, in an enantioselective fashion.
Exposing the latter to heat, in the presence of BHT, provided
access to aldehyde 128, efficaciously building up the tricyclic core
of the leucosceptroids. Unfortunately, their attempts to intro
duce the C6 methyl group, by alkene epoxidation and ring
opening with an appropriate organometallic reagent, have not
yet been successful.Scheme 15 (a) Molecular structures of ( ) ircinianin and (+) wistarin,
(b) Uenishi’s asymmetric synthesis: the key NHK/Diels Alder sequence
to construct the tricyclic core structure. rt room temperature.5 Tricarbocyclic sesterterpenoids
5.1 Gascardic acid
The group of Boeckman Jr. has demonstrated a longstanding
interest in sesterterpenoid synthesis, producing a number of
important contributions in this field. Among these contributions
was their successful total synthesis of gascardic acid (136) in
1979,91 the first truly structurally complex sesterterpenoid to have
been made synthetically. Gascardic acid (136) was isolated in
1960,92 and despite the careful investigation shortly following its
isolation,93 the relative configurations of the two side chain ster
eocenters were not unambigously proven.94Thus, the synthesis by
Boeckman et al. not only explored and pioneered new chemistry,
but their work also clarified the structure of the natural product’s
unique molecular structure consisting of a [5 6 7] ring system and
two adjacent quaternary stereogenic centers.This journal is ª The Royal Society of Chemistry 2012 Nat. Prod. Rep., 2012, 29, 752 779 | 763
 View Article OnlineThe Boeckman synthesis of gascardic acid (136) was initiated
by a conjugate addition/annulation process: Michael addition to
cyclopentenone 129, employing mixed cuprate 137, followed by
trapping the resulting copper enolate with a trimethylsilylvinyl
ketone 138, succinctly provided (after workup and base medi
ated cyclization) the key hydrindenone 130 (Scheme 17). It was
expected that such a cyclization would result in a cis relationship
between the angular methyl group and the orientation of the side
chain, based on earlier work in the same laboratories. The
stereochemical outcome followed their prediction, unfortu
nately, however, the stereogenic center present in the side chain
was formed as a mixture of epimers (1 : 1) and was carried
forward without separation. The next task facing the authors was
to install a second quaternary stereogenic center in a sterically
congested position. Since strategies based on organo cuprate
reagents were not successful, the group resorted to a [3,3] sig
matropic rearrangement to achieve the desired functionalization.
Vinyl ether 131, available in five steps from ketone 130, was
heated (160 C) to affect a Claisen rearrangement, giving the
desired aldehyde 132 as a single isomer in good yield (65%). After
oxidation of the aldehyde to the corresponding acid, an iodo
lactonization was performed and the resulting intermediate
lactone was directly converted to epoxide 133 by solvolysis with
NaOMe and base mediated oxirane ring closure. Elaboration of
this compound to exo methyene hydrindane 134 proved prob
lematic, but could be accomplished in four steps. Lewis acid
promoted rearrangement of the epoxide in 133 gave the ther
modynamically more stable ketone. This was followed by
saponification and an unusual olefination via adding lithium
species 139 and subsequent reductive elimination. Finally,
treatment with CH2N2 gave diester 134 in good overall yield.
Closure of the final ring via a regioselective Dieckmann reaction
was affected by treatment with LiTMP. The synthesis was then
completed as follows: chemoselective reduction of the ketone,
mesylation and elimination yielded the racemic methyl ester 135.
At that point, Boeckman et al. separated the mixture of epimers
by means of liquid chromatography. Comparison of the spectral
data revealed that their synthetic material was identical to anScheme 16 (a) Molecular structure of the sesterterpenoids (+) leuco
screptroid A and D, (b) Horne’s intramolecular Diels Alder approach.
TBS tert butyldimethylsilyl, BHT 2,6 di tert butyl 4
hydroxytoluene.
764 | Nat. Prod. Rep., 2012, 29, 752 779authentic sample of natural methyl gascardate. At last, saponi
fication of methyl ester 135 delivered racemic gascardic acid
(136). Later that year, Boeckman and Clardy verified the struc
ture of gascardic acid (136) by X ray analysis of its
dicyclohexylammonium salt.95 However, the absolute configu
ration of this natural product has not been clarified to date.5.2 Ophiobolins
The fungal metabolite (+) ophiobolin A (140)96 was the first
naturally occurring sesterterpenoid identified. Since its isolation
in 1958, several congeners have been isolated showing the same
carbon skeleton A (Fig. 8). In addition to their complex and
structurally daunting [5 8 5] tricarbocyclic ring system, this class
of natural products shows potent anti bacterial and anti fungal
properties, as well as cytotoxicity in different cancer cell lines.97
These characteristics have made the ophiobolins attractive
targets for synthetic studies.98 However, despite the considerable
effort expended in such endeavours, only one synthesis of
(+) ophiobolin C (141)99 has been reported by the laboratories of
Kishi in 1989,100 and very recently, more than 50 years after its
isolation, Nakada reported the total synthesis of (+) ophiobolin
A (140) in 2011.101
Kishi et al. pointed out that one major challenge in the
synthesis of the ophiobolin family rested on the difficulties
associated with constructing the ring system, in particular the
eight membered ring.100,102 This problem was addressed by
taking advantage of an intramolecular NHK reaction. At the
beginning of their lengthy, but ultimately successful enantiose
lective route, Kishi et al. transformed 3 endo bromocamphor 142
over a series of six steps into alcohol 143, setting two stereogenic
centers of the natural product (Scheme 18).103After ozonolysis of
the exocyclic double bond, protection of the primary alcohol and
Saegusa Ito oxidation, then reduction of the enone under Luche
conditions, allylic alcohol 144 was obtained (3 : 1 mixture in
favor of the desired b isomer). The latter was coupled with acid
chloride 152 under basic conditions, setting the stage for
a domino Brook/Claisen rearrangement to install the pendant
side chain of (+) ophiobolin C (141). The desired cascade took
place upon heating the ester 145 at 230 C in xylenes to yield
(after hydrolysis of the intermediate silyl ester) acid 146 in high
yield (72%) and good diastereoselectivity (6 : 1). With this
important intermediate in hand, the functional groups were
manipulated in a straightforward fashion over a nine step
sequence, giving rise to aldehyde 147. This product was treated
with vinyl lithium reagent 153 (prepared asymmetrically starting
from ( ) tartaric acid),104 followed by re pivaloylation of the
partially deacylated product to furnish the vinylogous hemiacetal
148, which in turn underwent hydrolysis to the enone (not
shown). Another three step sequence consisting of iododesilyla
tion, selective deprotection of the THP ether and Swern oxida
tion finally provided aldehyde 149 as the key intermediate for the
NHK reaction. In this event, subjecting aldehyde 149 to a large
excess of CrCl2 and a catalytic amount of NiCl2 led to the desired
key C C bond formation, successfully installing the [5 8 5] tri
carbocyclic framework in alcohol 150. The product was obtained
as a single isomer with its relative stereochemistry assigned
according to model studies, without being unambiguously
proven.104 To complete the remaining functional groupThis journal is ª The Royal Society of Chemistry 2012
Scheme 17 Boeckman’s racemic synthesis of gascardic acid showcasing the utility of [3,3] sigmatropic rearrangements to install quaternary stereogenic
centers in congested positions. LiTMP 2,20,6,60 tetramethylpiperidinyl lithium, Ms methanesulfonyl, DBU 1,8 diazabicyclo[5.4.0]undec 7 ene,
TMS trimethylsilyl.
Fig. 8 Molecular structures of (+) ophiobolin A, (+) ophiobolin C and
the ophiobolin skeleton.
 
View Article Onlinemanipulations needed, Kishi et al. transposed the allylic alcohol
via epoxidation of the exocyclic double bond, then thiocarbonate
formation and Sn mediated radical reductive ring opening, that
was accompanied by diastereoselective conjugate reduction of
the enone, to yield alcohol 151. An additional six steps finally
provided (+) ophiobolin C (141) with analytical data in agree
ment with that obtained from an authentic sample.
30 years after Kishi’s synthesis of ophiobolin C (141), Nakada
and co workers presented their successful route toward
(+) ophiobolin A (140).101 Within that time range, powerful
synthetic tools were developed that provided new opportunities
to address complex synthetic targets. Hence, Nakada et al.
envisaged to close the B ring of ophiobolin A (140) by means of
an RCM reaction. The authors stated that such a reaction to
install a tri substituted double bond in an eight membered ring isThis journal is ª The Royal Society of Chemistry 2012highly challenging and not well precedented in the literature.
Moreover, they planned to generate the spirocyclic tetrahydro
furan moiety via a Lewis acid promoted cyclization. Their route
was initiated by an enzymatic desymmetrization, giving rise to
acid 154, containing one quaternary stereogenic center, in 96% ee
(Scheme 19). Following that, a 15 step sequence was required to
prepare alkyl iodide 155. Subsequent treatment with t BuLi
generated the corresponding organo lithium species, which was
trapped by enantiomerically pure lactone 163 (prepared via
diastereoselective a allylation chemistry employing an Evans’
auxiliary) to provide hemiketal 156. After which, the above
mentioned cyclization was explored, discovering that exposure of
lactol 156 to BF3 etherate resulted in the formation of spirocycle
157, albeit in a modest yield of 45%.105,106 Nakada et al. then
shifted their focus toward closing the eight membered ring. To
this end, the terminal alkene 157 was hydroborated and the
resulting primary alcohol protected as its pivaloyl ester. Cleavage
of the MOM ether and Dess Martin oxidation gave rise to
aldehyde 158, that was subjected together with cyclopentanone
164 to Reformatsky type reaction conditions, using Ph3SnH and
Et3B. The boron enolate generated in situ reacted smoothly with
aldehyde 158 to furnish the aldol product as a single isomer (90%
yield, not shown), which was subsequently dehydrated with
Burgess reagent to give enone 159 as a single diastereomer.
Next, the authors set the last two stereogenic centers in
ophiobolin A (140) by taking advantage of substrate control:
hydrogenation in the presence of RANEY Ni followed by
exposure to MeLi yielded diol 160 with excellent diastereo
selectivity, cleaving the pivaloyl ester in the process. A rather
long, 15 step sequence was needed to arrive at the RCM
precursor, diene 161, mainly due to protecting groupNat. Prod. Rep., 2012, 29, 752 779 | 765
Scheme 18 Kishi’s asymmetric synthesis of (+) ophiobolin C using an intramolecular NHK reaction. DHP 3,4 dihydro 2H pyran, PPTS pyr
idinium p toluenesulfonate, Saegusa Ito TMS enol ether formation, then Pd(OAc)2, THP 2 tetrahydropyranyl, KHMDS potassium hexame
thyldisilazide, Piv pivaloyl, TMS trimethysilyl, TBAF tetrabutylammonium fluoride, pTsOH p toluenesulfonic acid, Swern Me2SO,
(COCl)2, then Et3N, TBDPS tert butyldiphenylsilyl, py pyridine, acac acetylacetone, AIBN 2,2
0 azobis(2 methylpropionitrile), TBS tert
butyldimethylsilyl, Bn benzyl.
 
View Article Onlinemanipulations, owing to the RCM reaction’s sensitivity toward
steric congestion. They were ultimately successful, however, as
subjecting diene 161 to the Grubbs Hoveyda II catalyst in the
presence of 1,4 benzoquinone at 110 C closed the eight
membered ring, yielding diol 162. Having correctly set all ster
eogenic centers and established the tetracyclic framework,
Nakada et al. finished the synthesis employing a straightforward
six step protocol to give, at long last, the first successful total
synthesis of (+) ophiobolin A (140).5.3 Ceroplastins
Shortly following the identification of the ophiobolins, was the
discovery of other di and sesterterpenoids bearing a [5 8 5] tri
carbocyclic core. As mentioned earlier, synthesis of such
a carbon skeleton was considered challenging, especially the
central eight membered ring, thus these natural products
provided a platform to develop new synthetic methods for
the generation of medium sized rings.98,102 One class of such
sesterterpenoids possessing a [5 8 5] system includes the
ceroplastins, represented by (+) ceroplastol I (165),107 (+) cer
oplastol II (166)108 and (+) albolic acid (167),109 as shown in766 | Nat. Prod. Rep., 2012, 29, 752 779Fig. 9. The carbon skeleton of the ceroplastins bears a likeness to
that of the ophiobolins, and the first synthesis of rac ceroplastol I
(165) was reported by Boeckman et al. as a back to back
publication in the same issue as Kishi’s total synthesis of
(+) ophiobolin C (141).110
Contrary to Kishi’s strategy (forming the eight membered ring
using a NHK reaction), Boeckman constructed the eight
membered ring via the fragmentation of an appropriately func
tionalized [3.3.1] nonanone system. To achieve this goal, they
quickly built up a tricyclic system, starting from racemic bis
carbonyl compound 168, by conjugate addition to Michael
acceptor 177, followed by pTsOH mediated aldol condensation
to yield tricyclic enone 169 as a 4.9 : 1 mixture of epimers
(Scheme 20). Exploiting the bias of the tricyclic system, the group
installed the quaternary stereogenic center in lactone 170 with
complete stereocontrol during a five step sequence, involving
three carbon chain extension and cyclization. A diaster
eoselective Michael addition to enone 170 was accomplished
using mixed cuprate 178, and the resulting lactone was sol
volyzed with LiOMe to furnish ester 171. The [3.3.1] nonane
scaffold was then built using a series of redox reactions.
Although the authors did not specify the precise identity of theThis journal is ª The Royal Society of Chemistry 2012
Scheme 19 Nakada’s enantioselective synthesis of (+) ophiobolin A employing an RCM to construct the eight membered ring. Ph phenyl, TMS
trimethylsilyl, MOM methoxymethyl, TBDPS tert butyldiphenylsilyl, 9 BBN 9 borabicylo[3.3.1]nonane, Piv pivaloyl, DMP Dess Martin
periodinane, Burgess reagent (methoxycarbonylsulfamoyl)triethylammonium hydroxide, inner salt, TBS tert butyldimethylsilyl, Bn benzyl.
Fig. 9 Molecular structures of the ceroplastins.
 
View Article Onlineintermediates in this sequence, it involved a Dieckmann cycli
zation that ultimately gave rise to tricyclic ketone 172. An
additional four step protocol, including a regio and diaster
eoselective reduction of the diketone with LiAl(Ot Bu)3H,
eventually leading to mesylate 173, the substrate for the key
Grob fragmentation reaction. As expected, treating ketone 173
with NaOMe in boiling MeOH resulted in the formation of
diester 174, bearing a suitably functionalized eight membered
ring. After establishing the [5 8 5] tricarbocyclic framework via
another Dieckmann condensation followed by Krapcho decar
boxylation, the authors converted the resulting cyclopentanone
under Saegusa Ito conditions into enone 175. In order to install
the side chain, Michael acceptor 175 was reacted with cuprate
179 to yield ketone 176 as an inseparable 1 : 1 mixture of
epimers. The next task at hand was to deoxygenate, and
Boeckman et al. were pleased that the transformation of ketone
176 to the corresponding tosylhydrazone not only cleaved the
TBS ether as well, but also allowed for separation of the epimers
(from the cuprate addition) by preparative TLC. Finally,
reduction under quite forcing conditions using ZnCl2/NaCNBH3
in MeOH (90 C) afforded racemic ceroplastol I (165).
In 1993, Paquette and co workers presented an enantiose
lective route to (+) ceroplastol I (165).111 They began by utilizing
the readily available asymmetric building block: acetal protected
ketone 180, and converted it into lactone 181 over ten steps
(Scheme 21). The latter underwent a sequential Tebbe olefina
tion/Claisen rearrangement, generating (via diene 182) the eight
membered ring with a cis junction that could be equilibratedThis journal is ª The Royal Society of Chemistry 2012with methanolic K2CO3 to yield the trans fused bicycle 183.
After 1,3 carbonyl transposition, requiring five steps, Paquette
et al. obtained enone 184 and used cuprate 186 to introduce the
last ring, employing a Michael addition/annulation protocol
developed earlier by Piers.112 Prior to finishing the synthesis with
an endgame similar to that reported by Boeckman, Paquette
transformed the resulting ketone in tricycle 185 into a trisubsti
tuted alkene via formation of the corresponding enol triflate and
subsequent methyl cuprate addition.
In comparison to (+) ceroplastol I (165), its double bond
isomer (+) ceroplastol II (166) is lacking one stereocenter, as the
exocyclic double bond present in the former is shifted one carbon
over in the latter, situating it at the ring junction. Nevertheless,
this sesterterpenoid 166, as well as its oxidized form (+) albolic
acid (167), resisted synthetic attempts until Kato et al. reported
its first, and thus far only, total synthesis in 1988.113,114 Over the
course of this endeavor, the group planned to construct the
crucial eight membered ring using a number of interestingNat. Prod. Rep., 2012, 29, 752 779 | 767
Scheme 20 Boeckman’s racemic synthesis of ceroplastol I constructing the eight membered ring via a Grob type fragmentation. DBN 1,5 di
azabicyclo[4.3.0]non 5ene, pTsOH p toluenesulfonic acid, MOM methoxymethyl, EE ethoxyethyl, CAN ammonium cerium(IV) nitrate,
OMs methanesulfonyl, Saegusa Ito lithium diisopropylamide, then Pd(OAc)2, KHMDS potassium hexamethyldisilazide, TBS tert butyldi
methylsilyl, TsNHNH2 p toluenesulfonyl hydrazide, prep. TLC preparative thin layer chromatography.
Scheme 21 Paquette’s asymmetric synthesis of (+) ceroplastol I
exploiting a Tebbe olefination/Claisen rearrangement sequence. Tebbe
Cp2TiCl2, AlMe3 premixed.
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rearrangement and a pinacol coupling/cyclization. Their
synthetic program initiated with racemic ester 187, which
underwent a TiCl2 mediated reductive cyclization to yield diol
188 as the major product (Scheme 22). To render their synthesis
asymmetric, the authors conducted an optical resolution of the
corresponding acid. Further transformations delivered both
enantiomers of aldehyde 189 over a total of eight steps each.114c It
is noteworthy that this classical resolution cannot be considered
wasteful, since both enantiomers were eventually used in the
synthesis. The aldehyde (S) 189 was transformed over six steps
into allylic chloride 190, which in turn was subjected to a CrCl2
promoted reductive coupling with aldehyde (R) 189 in the pres
ence of iso PrOH, providing alcohol 191 in 88% yield. The
coupling product was converted over a sequence of six steps to
TMS protected lactol 192, which served as a substrate for an
unusual oxy Cope rearrangement. The expected chair like tran
sition state of such a rearrangement would have resulted in the
wrong stereochemical outcome at the quaternary stereogenic
center, so Kato et al. biased the system to adapt a normally
disfavored boat like transition state, by sequestering the hydroxy
group in a six membered silyl lactol. Upon heating this lactol 192
to 190 C, the rearranged dihydropyran 193 was obtained in
good yield. Next, the authors employed a series of chemical
transformations to access bisaldehyde 194, the precursor for the
key reductive cyclization. Once again employing TiCl2, dicar
bonyl compound 194 cleanly underwent pinacol coupling to give
diol 195 as a single diastereomer (the relative stereochemistry at
one stereocenter could not be assigned unambiguously). A
subsequent Birch reduction of the corresponding diacetate with
concomitant cleavage of the pivaloyl ester gave rise to alcohol
196, possessing the tricarbocyclic core of (+) ceroplastol II (166).768 | Nat. Prod. Rep., 2012, 29, 752 779Extension of the side chain required seven additional steps,
giving ester 197, that was used to complete the total synthesis of
two sesterterpenoids in a divergent manner: saponification of the
ester with NaOH provided the corresponding acid, (+) albolicThis journal is ª The Royal Society of Chemistry 2012
 View Article Onlineacid (167), whereas treatment with LiAlH4 resulted in the
synthesis of (+) ceroplastol II (166).
5.4 Miscellaneous tricarbocyclic sesterterpenoids
In addition to the ophiobolanes, ceroplastols and gascardic acid,
a few other tricarbocyclic sesterterpenoids have captured the
attention of synthetic chemists. Most of this attention has been
directed at natural products possessing the cheilanthane skeleton
B (Fig. 10). This topic however, has been reviewed in detail by
Ungur and Kulcitxki in 2009,115 and their account covers the
completed syntheses of ( ) hyrthiosal (198),116,117 which features
a rearranged carbon skeleton. Since then, Fekih et al.118 reported
the semisynthesis of the cheilanthane sesterterpenoid ( ) petro
saspongianolide R (199).119
The synthesis of another tricarbocyclic sesterterpenoid,
( ) nitiol (200) (Fig. 11),120 a potent enhancer of IL 2 gene
expression in human T cell lines, was attempted, and almost
achieved, by Dake and co workers.121 In their enantioselective
approach, they constructed the carbon framework utilizing
a Norrish Type I fragmentation (not shown), and successfully
installed the cis relationship between the A ring methyl and iso
propyl groups. However, due to a problematic deoxygenation,
their attempts to convert dihydroxynitiane 201 into ( ) nitiol
(200) have so far been unfruitful.121b
6 Tetracarbocyclic sesterterpenoids
6.1 Cerorubenic acid-III
( ) Cerorubenic acid III (202) was first isolated in 1983 by Naya
et al., and plays a role in insect communication (Fig. 12).122 From
a series of detailed NMR experiments, the authors assigned its
structure as consisting of a unique tetracyclo[8.4.1.0.0]pentade
cane skeleton with a pendant side chain, seven contiguousScheme 22 Kato’s enantioselective synthesis of (+) ceroplastol II and (+) a
methylsilyl, Piv pivaloyl, Ac2O acetic anhydride.
This journal is ª The Royal Society of Chemistry 2012stereogenic centers and an embedded vinylcyclopropane motif,
its alkene moiety residing at a bridgehead site.
A campaign that spanned more than a decade in the Paquette
group has spawned several published approaches to ( ) ceror
ubenic acid III (202),123 culminating in a report of its total
synthesis in 1998 that confirmed both the original structural
assignment and its absolute configuration.124 Their successful
approach started from cyclohexenone 203, by Michael addition
of diethyl malonate, then saponification and decarboxylation to
assemble 1,5 keto acid 204 (Scheme 23). An acid catalyzed
Claisen condensation, followed by an intramolecular oxidative
coupling that proceeded through a dienolate intermediate, gave
access to CS symmetric diketone 205. Subsequent mono
methylenation gave unsymmetrical ketone rac 206, that was
resolved by 1,2 addition with chiral lithiated sulfoximine 139 and
separation of the resulting diastereomers by column chroma
tography. Independent pyrolysis of each diastereomer furnished
both antipodes of ketone 206 in optically pure form. After ster
eoselective addition of vinylmagnesium bromide to afford
alcohol 207, the stage was set for the key step of the synthesis: an
anionic oxy Cope rearrangement, a signature reaction of the
Paquette group. Indeed, treating alcohol 207 with KHMDS in
refluxing THF triggered the formation of tricyclic anti Bredt
alkene 208 in a remarkably efficient 88% yield. In preparation for
annulation of the D ring, a four step sequence gave silyl ether
209, which in turn was attacked by the lithium salt of phosphine
oxide 215. Following desilylation and phosphinate elimination,
the resultant isomeric enol ethers 210 were transformed into
allylic iodide 211, requiring seven synthetic operations. A Kno
chel chain extension was used to insert a methylene unit, by
reacting iodide 211 with ICH2ZnI in the presence of CuI and LiI,
extending the allylic iodide chain by one carbon unit to afford
homoallylic iodide 212. Paquette’s various published approaches
to ( ) cerorubenic acid III (202) explored several attempts tolbolic acid: ring closure by a pinacol coupling. Bn benzyl, TMS tri
Nat. Prod. Rep., 2012, 29, 752 779 | 769
Fig. 10 Molecular structures of the cheilanthane skeleton and the two
members ( ) hyrtiosal and ( ) petrosaspongianolide R.
Fig. 12 The molecular structure of ( ) cerorubenic acid III.
 
View Article Onlineincorporate the final six membered ring, including two different
Robinson annulation strategies.123c,d Ultimately, only a radical 6
exo cyclization tactic proved successful. Upon subjecting
homoallylic iodide 212 to free radical generating conditions
(n Bu3SnH, AIBN) the authors obtained the cyclized product,
ester 213, with the desired stereochemistry at both of the newly
formed stereogenic centers (single diastereomer at the ring
junction, 4.9 : 1 mixture of epimers at the side chain). The details
concerning the stereoselectivity of this key step are discussed at
length in the full paper.124 Stepwise redox/chain extension via
successive Horner Wadsworth Emmons reactions delivered
( ) cerorubenic acid III methyl ester (214), that was indistin
guishable from an authentic sample.
6.2 Miscellaneous tetracarbocyclic sesterterpenoids
Among the tetracarbocyclic sesterterpenoids, there exists a large
subclass that is host to the scalarane scaffold C (Scheme 24).125
Owing to their range of anti microbial and cytotoxic activities,
scalaranes have been targets of numerous synthetic studies, many
of which are semi syntheses starting from either a structurally
related sesterterpenoid, or ( ) sclareol (219) (a readily available
diterpene building block). The synthesis of scalaranes has already
been summarized, together with a description of isolation and
biological activities, in a review from 2004.126 Since then, it has
remained an active area of research, evidenced by successful
syntheses of the scalaranes (+) scalarolide (218),9,127 ( ) sester
statin 4 (217),128,129 its epimer ( ) sesterstatin 5 (220)128,129 and
(+) 16 deacetoxy 12 epi scalarafuranacetate (221)130,131 recently
appearing in the literature. Notably, the latter three completed
targets exhibit potent cytotoxic activity, likely stimulating
further synthetic and biological studies on related natural
products and structural analogs within this compound class.
One such report has been published by Kamel and Slattery in
2009.132 Therein, they accomplished the semisynthesis of 20Fig. 11 Molecular structures of ( ) nitiol and Dake’s advanced inter
mediate 201. TBDPS tert butyldiphenylsilyl.
770 | Nat. Prod. Rep., 2012, 29, 752 779natural and synthetic scalarane analogues starting from the
naturally abundant metabolite heteronemin (216).133 In addition,
they conducted biological tests regarding cytotoxicity against
different cancer cell lines as well as anti microbial activities.
In 1997, Piers et al.134 reported a synthesis of ( ) variecolin’s
(222)135 [5 8 5] core (Scheme 25). The Piers group had nearly
completed its total synthesis in 2002, as described in S. D. Walk
er’s Ph.D. thesis.136 Unfortunately, they were unable to produce
enough material to investigate the conversion of either racemic
5 deoxyvariecolin (not shown) into variecolin (222) or 5 deoxy
variecolol (223) and 5 deoxyvariecolactone (224) into the corre
sponding natural products.137 At around the same time, in 2001,
Molander’s group published an enantioselective approach to the
same target.138 They planned to take advantage of a sequenced
SmI2mediated coupling, which they expected to be a viablemeans
to produce cyclooctanoid hemiketal 225. Although their model
studies demonstrated the general feasibility of the coupling step,
only the asymmetric synthesis of the required building blocks 1,3
keto ester 226 and 4 chloro ketone 227 were reported, with no
description of their use in the key coupling step so far.
Uemura et al.139 developed an enantioselective route to the
tetracarbocyclic core of mangicol A (228)140 in 2004 (Fig. 13).
They invoked a stereoselective transannular Diels Alder reac
tion to access spirocycle 230, possessing the majority of the
requisite carbon skeleton and functionality. In addition to
Uemura et al., the Paquette group conducted initial studies
aimed at establishing routes toward (+) mangicol A (228).141
More recently, Sarpong et al. described a preliminary investiga
tion into the synthesis of related structure (+) neomangicol C
(229),140 preparing tetracyclic ketone 231 as a racemate via
intramolecular addition of an indene to an aldehyde.142
The sesterterpenoid YW3699 (232),143 with its daunting [5 8 6
5] tetracarbocyclic core, is a potent inhibitor of GPI anchor
biosynthesis, whose absolute configuration and relative config
uration at the heptanoate side chain is unknown to date (Fig. 14).
It drew the interest of Tori et al., who prepared an advanced
intermediate en route to the natural product, tricarbocycle 233,
using RCM to effectively close the central eight membered
ring.144 Noteworthy, the epimeric epoxide did not undergo ring
closure. Their model system, however, has not yet addressed the
installation of the crucial trans hydrindane moiety found in
YW3699 and related molecules. With a cis relationship between
its angular methyl and iso propyl substituents, this represents
a significant synthetic challenge.7 Pentacarbocyclic sesterterpenoids: Retigeranic
acid
Among the known members of this rare sesterterpenoid class,
( ) retigeranic acid A (234)145 remains the only one that hasThis journal is ª The Royal Society of Chemistry 2012
Scheme 23 Paquette’s asymmetric synthesis of ( ) cerorubenic acid III methyl ester featuring an anionic oxy Cope rearrangement and a free radical
cyclization. PPA polyphosphoric acid, LDA lithium diisopropylamide, FCC flash column chromatography, KHMDS potassium hexame
thyldisilazide, TBAF tetrabutylammonium fluoride, AIBN 2,20 azobis(2 methylpropionitrile).
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from the Himalayan lichen Lobaria retigera,145a the structure of
acid 234 was not fully assigned until seven years later by Shibata
et al., who were able to obtain an X ray crystal structure of its
p bromoanilide derivative.145c
However, during the Corey group’s pursuit of a retigeranic
acid (234) total synthesis in the early 1980s (see below),146 they
discovered that an authentic sample of retigeranic acid, which
they obtained from Shibata, was in fact a mixture of two dia
stereomers. This was learned by the esterification of natural
retigeranic acid with CH2N2, which enabled separation of the
corresponding ester derivatives using HPLC. Furthermore, it
was found that ( ) retigeranic acid A (234)147 was actually the
minor component of the mixture. The structure of the major
component ( ) retigeranic acid B (235) was elucidated several
years later using X ray crystallography and finally published in
1991, again by Shibata. It turned out that acid 235 differs from its
counterpart 234 only by the iso propyl substituents’ relative
stereochemistry (Fig. 15).145d As a consequence of this molecule’s
complicated history, all four successful total syntheses targeted
the originally reported structure of ( ) retigeranic acid (234),
since the synthetic work was completed prior to Shibata
disclosing the identity of ( ) retigeranic acid B (235).
From a synthetic chemist’s point of view, retigeranic acid (234)
can be thought to possess an intimidating molecular structure,
being comprised of several noteworthy features: eight stereogenic
centers, two of which are quaternary, and a unique penta
carbocyclic skeleton. This framework includes a trans hydrin
dane and a triquinane moiety that together comprise four
five membered and one six membered ring. Remarkably, the
molecule has only a single oxygenated site, namely a lone
carboxylic acid functionality. Often labelled as a classic target inThis journal is ª The Royal Society of Chemistry 2012total synthesis,148,149 retigeranic acid (234) has provided
numerous challenges for the groups of Corey,146 Paquette,150
Hudlicky151 and Wender,152 all of whom were ultimately
successful undertaking its synthesis.
The Corey group was the first to complete the total synthesis of
retigeranic acid (234) in 1985, ensuring its subsequent popularity
as a synthetic target.146 One of the most obvious stumbling
blocks they faced, the diastereoselective installation of the crucial
quaternary center embedded within the triquinane system, was
addressed elegantly with an intramolecular ketene/alkene [2 + 2]
cycloaddition. It was anticipated that subsequent ring expan
sion/ring contraction processes could be exploited to access to
the required triquinane moiety. They elected to begin their
synthesis from racemic hydrindenone 236, which was readily
available via Robinson annulation.153 The authors chose to
employ a substrate directed hydrogenation to set the trans ring
junction in alcohol 237, since formation of the strained trans
hydrindane ring system is usually thermodynamically unfa
vored.154 A short sequence of functional group manipulations
were carried out: a diastereoselective reduction of ketone 236
with LiAlH4, followed by alcohol inversion using Mitsunobu
conditions. Directed hydrogenation in the presence of cationic
Rh catalyst 247 under high pressure (950 psi) furnished the
desired trans hydrindane 237 (Scheme 26). Subsequently, the
alcohol was re oxidized to the corresponding ketone using Jones’
reagent. A two step protocol commencing with vinyl Grignard
addition, followed by elimination of water yielded diene 238,
which in turn served as a substrate for the Diels Alder reaction
with dienophile 248. The desired [4 + 2] cycloadduct 239 was
produced in 61% yield as the major isomer, and six additional
steps were needed to prepare carboxylic acid 240, the precursor
for the key [2 + 2] cycloaddition. Treatment with oxalyl chlorideNat. Prod. Rep., 2012, 29, 752 779 | 771
Scheme 24 (a) Molecular structures of the scalarane skeleton C and the
natural product heteronemin, (b) recently reported semisyntheses of
biologically active scalaranes starting from ( ) sclareol.
Scheme 25 (a) Molecular structure of ( ) variecolin, (b) deoxygenated
natural products synthesized by Piers, (c) Molander’s retrosynthetic
analysis and building blocks 220 and 221 prepared in an enantioselective
fashion. PG protecting group.
Fig. 13 (a) Molecular structures of (+) mangicol A and (+) neo
mangicol C, (b) core structure 230 asymmetrically prepared by Uemura
via a Diels Alder reaction, (c) Sarpong’s racemic tetracyclic intermediate
231.
Fig. 14 Molecular structures of GPI anchor inhibitor YW3699 and
Tori’s tricarbocycle 233 prepared by RCM.
Fig. 15 Molecular structures of ( ) retigeranic acids A and B.
772 | Nat. Prod. Rep., 2012, 29, 752 779
 
View Article Onlineand Et3N generated the corresponding ketene 241 in situ,
smoothly giving rise to cyclobutanone 242 in 80% yield, thereby
accomplishing diastereoselective incorporation of the all carbon
quaternary center. The ring expansion of cyclobutanone 242 to
the corresponding cyclopentanone was initiated by the addition
of lithiated dithiane 249, giving rise to carbonyl adduct 243 in
73% yield. A subsequent CuOTf mediated thio pinacol rear
rangement in the presence of Et3N was followed by a two step
desulfurization sequence: oxidation with NaIO4 and then
reductive C S bond cleavage with Al/Hg. The resulting cyclo
pentanone 244, obtained in 65% overall yield, was later trans
formed into alkene 245 over a five step sequence that included
olefin hydrogenation, methyl group epimerization and deoxy
genation via modified Wolff Kishner reduction. The final
remaining hurdle was to introduce the triquinane motif via ring
contraction. This was made possible in four steps, starting with
OsO4 promoted dihydroxylation, followed by glycol cleavage
with Pb(OAc)4 yielding dialdehyde 246 that was surrendered to
Al2O3, which affected aldol ring closure. At long last, a Pinnick
oxidation concluded the synthesis, providing access to racemic
retigeranic acid (234) in 32 steps (longest linear sequence).This journal is ª The Royal Society of Chemistry 2012
 View Article OnlineIn contrast to Corey’s linear synthesis, Paquette et al. adopted
a more convergent strategy in their enantioselective route to
( ) retigeranic acid (234), reported in 1987.150 They intended to
attach the A ring via 1,4 addition to a triquinane fragment then
close the B ring late in the synthesis using an intramolecular aldol
condensation. The required triquinane building block 259 was
synthesized starting from (+) pulegone (250).155 The latter was
brominated, then treated with NaOMe to trigger a Favorskii
rearrangement with concomitant elimination of bromide.
Subsequent ozonolysis yielded cyclopentanone 251,156 that was
alkylated with tosylate 253 under basic conditions (Scheme 27).
A ketone functionality was then unmasked by ozonolysis,
enabling ring closure by aldol condensation. Subsequent heating
of the product in the presence of LiI affected decarboxylation of
the ester, yielding bicyclic enone 252 as a separable 2 : 1 mixture
of diastereomers. The remaining two stereogenic centers in
triquinane 259were set in two steps: a diastereoselectiveMichael
addition of the cuprate derived from Grignard reagent 254,
followed by HCl mediated acetal hydrolysis that resulted in
spontaneous aldol cyclization and furnished triquinane 257 as
a mixture of epimers. Next, thiocarbonate formation and
subsequent Chugaev type elimination yielded alkene 258.
Finally, Wolff Kishner reduction and a chromium mediated
allylic oxidation of the corresponding hydrocarbon gave access
to the desired triquinane building block 259. It is worth noting
that formation of enone 259 was accompanied by significant
amounts (ca. 30%) of the undesired 1,3 transposed enone. This
certainly represented a drawback, since separation from the
desired product was only possible upon reduction to the alcohol
stage, thus an extra re oxidation step was added to the sequence
employed to obtain pure tricyclic ketone 259.
Paquette et al. once again turned to the chiral pool for the
synthesis of the second fragment, choosing to start from
( ) limonene (260).157 It was possible to access allylic alcohol 261
in six steps, which in turn was converted into ketone 262 via
Wittig Still rearrangement (utilizing stannane 256) followed by
ozonolysis and TBS protection. Formation of cylcopentenone
263 from ketone 262 required adjustment of both functionality
and relative stereochemistry. This net conversion was achieved
using a four step protocol that involved 1,3 ketone transposition/
enone formation, followed by the 1,4 addition of vinyl cuprate
(dr 77 : 23). Completion of the second fragment was accom
plished by Wolff Kishner reduction with simultaneous desily
lation, and conversion of the primary alcohol to bromide 264
with ZnBr2/DEAD/PPh3. The authors commented that the latter
transformation was exceptionally difficult due to the alcohol
being neopentylic and only Mitsunobu type conditions proved
effective. Having established viable routes to both fragments,
Paquette and co workers explored the key coupling step,
discovering that the Grignard reagent derived from alkyl
bromide 264 underwent exclusive 1,4 addition to sterically
hindered enone 259. Unfortunately, however, after ozonolysis of
the addition product, aldehyde 265 was obtained as the minor
diastereoisomer (dr 1 : 3), indicating that the 1,4 addition
was unselective. Closing the B ring via aldol condensation
required quite harsh conditions, namely piperidine and HOAc in
hot toluene for 48 h. These conditions led to partial epimeriza
tion of the aldehyde at the a position, producing the desired
trans configured product as the minor diastereomer (dr 1 : 4,This journal is ª The Royal Society of Chemistry 2012separated at the end of the synthesis by HPLC) and in modest
combined yield. The resulting enone system was hydrogenated in
the presence of PtO2 under elevated pressure (80 psi), giving rise
to an epimeric mixture of ketones 266. Paquette et al. were able
to finish the synthesis in four additional steps. First, ketone 266
was homologated via high pressure (100 000 psi) cyanohydrin
formation in the presence of KCN and 18 crown 6, then dehy
drated with POCl3 and DBU in boiling pyridine to give the
corresponding a,b unsaturated nitrile. Finally, DIBAL H
reduction and Pinnick oxidation provided ( ) retigeranic acid
(234), constituting its first asymmetric preparation.
Despite the convergent nature of Paquette’s synthesis, it
nevertheless required a large number of steps (26 steps, longest
linear sequence), and suffered from modest yields, especially due
to the low stereoselectivities obtained in late stage trans
formations. One year after Paquette’s work was published,
Hudlicky and co workers reported a shorter asymmetric
synthesis of ( ) retigeranic acid (234) with a longest linear
sequence of only 18 steps.151 Their strategy hinged on generating
the pentacyclic framework by forming the C ring via a [2 + 3]
annulation, involving the thermolysis of a vinyl cyclopropane
(vide infra). Hudlicky et al. selected (+) menthene (267) as
a starting material, carrying out its ozonolysis in the presence of
pTsOH/MeOH to protect the in situ formed aldehyde as its
dimethyl acetal. Regeneration of the aldehyde under mild acidic
conditions was followed by direct conversion to enamine 268
(Scheme 28). The latter was ozonolyzed, excising one carbon unit
to reveal an aldehyde. A subsequent HWE reaction with phos
phonate 275 was used to install a diene. Wittig methylenation of
the remaining methyl ketone then gave triene 269 setting the
stage for an intramolecular Diels Alder reaction to produce the
indane skeleton in ester 270. This transformation proceeded
diastereoselectively, but produced an inconsequential mixture of
double bond isomers in modest yield. Enol ether hydrolysis and
Krapcho decarboxylation finally yielded enantiomerically pure
hydrindane 271,158 which incidentally, also served as an inter
mediate in Corey’s retigeranic acid synthesis, albeit as a race
mate. In preparation for the key step, hydrindane 271 was
condensed with ethyl trimethylsilylacetate (276), and after
sequential bromination/monodehydro bromination, ester 272
was obtained. With this compound in hand, Hudlicky et al. were
poised to explore their annulation strategy. Adding the LDA
derived dienolate of ester 272 to enone 252 (cf. Scheme 27),
at 100 C resulted in 1,4 addition and subsequent nucleophilic
substitution, forming vinylcyclopropane 273 as an 1 : 1 mixture
of stereoisomers. Subsequently, flash vacuum pyrolysis of each
isomeric vinylcyclopropane 273 gave rise to ketone 274 with
good diastereoselectivitiy (4 : 1 to 2 : 1, depending on the isomer
used).151a From this point, erasure of the ketone was accom
plished in three steps by ketone reduction and BartonMcCombie
deoxygenation. Finally, saponification of the ethyl ester that
followed concluded their elegant total synthesis of ( ) retiger
anic acid (234).
The most recent synthesis of retigeranic acid (234) reported
thus far came from the Wender group in 1990.152 Intending to
close the B ring at a late stage via an intramolecular Diels Alder
reaction, their plan was contingent on construction of the tri
quinane portion by employing a photochemical arene alkene
cycloaddition, a methodology previously developed in theirNat. Prod. Rep., 2012, 29, 752 779 | 773
Scheme 26 Corey’s racemic synthesis of retigeranic acid employing a ring expansion/contraction strategy to install the quaternary center of the tri
quinane subunit. DEAD diethyl azodicarboxylate, Pinnick NaClO2, NaH2PO4, t BuOH.
 
View Article Onlinelaboratories. Starting from half ester 277 (readily available in
99% ee by enzymatic resolution of 3 methyl glutaric dimethyl
ester), six steps were required to furnish arene 278 (Scheme 29).
The pivotal photochemical cycloaddition proceeded efficiently,
but unfortunately furnished the desired tetracycle 279 as the
minor isomer (1 : 2 selectivity). It is noteworthy however,
that this transformation rapidly builds complexity and was
suitable for preparing multi gram quantities of tetracycle 279.
Cyclopropane ring opening and installation of the correct
functionality was accomplished by exposure to an acyl radical,
generated photochemically from formamide, resulting in addi
tion to the alkene and fragmentation of the intermediate cyclo
propylcarbinyl radical. The resulting amide product 280 was
then methylated, yielding triquinane 281, followed by allylic
oxidation with SeO2 to deliver aldehyde 282. Condensation of
the latter with the dianion of acid 287 (available in four steps
from (R) ( ) carvone) and subsequent decarboxylative dehy
dration afforded triene 283. Heating this Diels Alder precursor
(toluene, 250 C) yielded cycloadduct 284 as the major isomer
along with two isomers (one diastereomer, one double bond
regioisomer). Unfortunately, however, further isomerization of
the double bond into conjugation with the amide was problem
atic, and the authors instead opted for an indirect method by
epoxidation, base mediated ring opening and dehydration to
yield diene 285. Poor selectivity was observed for the following
high pressure hydrogenation step, furnishing the desired774 | Nat. Prod. Rep., 2012, 29, 752 779stereoisomer of pentacyclic amide 286 in only 25% yield. It was
possible however, to recycle the other isomeric products obtained
from this reaction. With simply oxidation state adjustment
required for completion of the synthesis, amide 286 was reduced
with LiAlH4, followed by stepwise oxidation using PDC and
Pinnick conditions, yielding ( ) retigeranic acid (234) after 20
steps (longest linear sequence). Similar to Paquette, Wender’s
approach was plagued by late stage selectivity problems that
were detrimental to the overall efficiency of the synthesis, leaving
room for improvement from future generations of synthetic
chemists. Since the 1990s however, no additional data toward the
synthesis of either ( ) retigeranic acid (234) or its diastereomer,
( ) retigeranic acid B (235) (Fig. 15), have surfaced in the liter
ature. Furthermore, to the best of our knowledge, no synthetic
groups have reported progress toward any other members of this
rare and beautiful class of sesterterpenoids.8 Conclusions
Herein, we have presented a few dozen total syntheses that have
yielded sesterterpenoids of varying complexity, ranging from
simple linear molecules to highly complex polycyclic systems.
These syntheses have featured much of the repertoire of modern
chemistry, including transition metal catalyzed C C bond
formations and macrocyclizations, cycloadditions, and rear
rangements. The rather lengthy sequences needed in many cases,This journal is ª The Royal Society of Chemistry 2012
Scheme 27 Paquette’s asymmetric synthesis of ( ) retigeranic acid featuring a Grignard reagent 1,4 addition and an aldol condensation to close the B
ring at last. py pyridine, HOAc acetic acid, Ac2O acetic anhydride, TBS tert butyldimethylsilyl, DEAD diethyl azodicarboxylate, TMS
trimetylsilyl, DBU 1,8 diazabicyclo[5.4.0]undec 7 ene, 18 C 6 1,4,7,10,13,16 hexaoxacyclooctadecane, DIBAL H diisobutylaluminum hydride,
Pinnick NaClO2, NaH2PO4, 2 methyl 2 butene, t BuOH.
Scheme 28 Hudlicky’s enantioselective synthesis of ( ) retigeranic acid utilizing a vinylcyclopropane rearrangement. pTsOH para toluenesulfonic
acid, LDA lithium diisopropylamide, DBU 1,8 diazabicyclo[5.4.0]undec 7 ene, AIBN 2,20 azobis(2 methylpropionitrile), TMS trimethylsilyl.
This journal is ª The Royal Society of Chemistry 2012 Nat. Prod. Rep., 2012, 29, 752 779 | 775
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Scheme 29 Wender’s asymmetric synthesis of ( ) retigeranic acid generating the triquinane subunit via a photochemical arene alkene cycloaddition. py
2 pyridyl, LDA lithium diisopropylamide, mCPBA m chloroperbenzoic acid, PDC pyridinium dichromate, Pinnick NaClO2, NaH2PO4, t
BuOH.
 
View Article Onlinee.g. in the synthesis of ophiobolin A (140) or retigeranic acid A
(234), reflect the structural complexity of sesterterpenoids but
also suggest that there is some room for improvement. It may be
worth revisiting some of the classic targets armed with a new set
of reagents and growing confidence that reactions can be carried
out with high chemoselectivity, thus avoiding protecting group
operations. As new members of the sesterterpenoid family are
discovered, and largely forgotten ones are unearthed, modern
synthetic methods will continue to be developed and refined
using this fascinating class of natural products.9 Acknowledgements
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